RELEVANCE OF TUMOR SIZE AND CELL-KINETICS AS PREDICTORS OF RADIATION RESPONSE IN HEAD AND NECK CANCER - RANDOMIZED STUDY ON EFFECT OF INTRA-ARTERIAL CHEMOTHERAPY FOLLOWED BY RADIOTHERAPY
RELEVANCE OF TUMOR SIZE AND CELL-KINETICS AS PREDICTORS OF RADIATION RESPONSE IN HEAD AND NECK CANCER - RANDOMIZED STUDY ON EFFECT OF INTRA-ARTERIAL CHEMOTHERAPY FOLLOWED BY RADIOTHERAPY
复制标题
DOI:
10.1002/1097-0142(197803)41:3
复制
发表时间:
1978-01-01
期刊:
影响因子:
6.2
通讯作者:
STARACE, G
中科院分区:
文献类型:
--
作者:
NERVI, C;ARCANGELI, G;STARACE, G
Size and extent of a primary tumor influences its response to irradiation. To investigate the relevance of this statement a randomized study was done in which irradiation of advanced carcinoma of head and neck was compared with combined treatment where preirradiation intraarterial chemotherapy was administered to reduce the extent of the tumor. Intraarterial chemotherapy (MTX [methotrexate] 3-5 mg/day for 25-35 days) was given to 72 patients with lesions in the oral cavity, oropharynx and maxillary antrum. Depending on response the patients were restaged and submitted to radiotherapy. In 68 other cases randomly allocated, radiotherapy only was given with the same modality and technique. After chemotherapy 21 cases with intraoral and 14 cases with maxillary antrum and oropharynx cancers were classified as stage I and II (0 and 23, respectively, before treatment). Results after 4 yr follow-up showed local control and survival statistically better in the combined treatment in intraoral cancer where irradiation was delivered by a combination of external and interstitial technique. In the other cases no statistically significant difference was found. Amelioration of the results in the oral cavity could be ascribed to the greater use of interstitial irradiation due to tumor shrinkage obtained with preirradiation chemotherapy more than to some synergistic effect between drug and irradiation. In 8 cases tumor cell kinetics were performed and the nuclear DNA content was measured, but none of the kinetic parameters could be correlated with the response to treatment, even when the cancers were grouped according to their clinical growth characteristics. Late results in the irradiation of head and neck cancer probably depends on the presence of some resistant component, which cannot be predicted by the cell kinetic or nuclear DNA content. Surgical excision or a 2nd course of chemotherapy must be considered as part of multimodality treatment.